LifeMD (NASDAQ: LFMD ) is not your average company, in terms of corporate structure. The firm was started in 1994 as ImmuDyne and went public in 2001. In 2018, the company was rebranded as Conversion Labs and finally came to its current iterationA longtime investor with a general interest in healthcare equities. I take a holistic investment approach that considers top-down and bottom-up valuation techniques. I find the more minute details of companies, including their capital structure and debt covenants, p ...